help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Originally published online as doi:10.2353/ajpath.2007.070056 on July 19, 2007

Published online before print July 19, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material
Right arrow All Versions of this Article:
ajpath.2007.070056v1
171/3/777    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Belmadani, S.
Right arrow Articles by Berecek, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Belmadani, S.
Right arrow Articles by Berecek, K. H.
(American Journal of Pathology. 2007;171:777-789.)
© 2007 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2007.070056

A Thrombospondin-1 Antagonist of Transforming Growth Factor-ß Activation Blocks Cardiomyopathy in Rats with Diabetes and Elevated Angiotensin II

Souad Belmadani*, Juan Bernal*, Chih-Chang Wei{dagger}, Manuel A. Pallero{ddagger}, Louis Dell’Italia{dagger}, Joanne E. Murphy-Ullrich{ddagger} and Kathleen H. Berecek*

From the Department of Physiology and Biophysics,* the Department of Pathology and the BioMatrix Engineering and Regenerative Medicine Center,{ddagger} and Department of Medicine,{dagger} Division of Cardiovascular Medicine, Center for Heart Failure Research, University of Alabama at Birmingham, Birmingham, Alabama

In diabetes and hypertension, the induction of increased transforming growth factor-ß (TGF-ß) activity due to glucose and angiotensin II is a significant factor in the development of fibrosis and organ failure. We showed previously that glucose and angiotensin II induce the latent TGF-ß activator thrombospondin-1 (TSP1). Because activation of latent TGF-ß is a major means of regulating TGF-ß, we addressed the role of TSP1-mediated TGF-ß activation in the development of diabetic cardiomyopathy exacerbated by abdominal aortic coarctation in a rat model of type 1 diabetes using a peptide antagonist of TSP1-dependent TGF-ß activation. This surgical manipulation elevates initial blood pressure and angiotensin II. The hearts of these rats had increased TSP1, collagen, and TGF-ß activity, and cardiac function was diminished. A peptide antagonist of TSP1-dependent TGF-ß activation prevented progression of cardiac fibrosis and improved cardiac function by reducing TGF-ß activity. These data suggest that TSP1 is a significant mediator of fibrotic complications of diabetes associated with stimulation of the renin-angiotensin system, and further studies to assess the blockade of TSP1-dependent TGF-ß activation as a potential antifibrotic therapeutic strategy are warranted.





This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. Tian, C. Li, J. Qi, P. Fu, X. Yu, X. Li, and L. Cai
Diabetes-induced upregulation of urotensin II and its receptor plays an important role in TGF-{beta}1-mediated renal fibrosis and dysfunction
Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1234 - E1242.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
L. A. Maile, B. E. Capps, E. C. Miller, A. W. Aday, and D. R. Clemmons
Integrin-Associated Protein Association With Src Homology 2 Domain Containing Tyrosine Phosphatase Substrate 1 Regulates IGF-I Signaling In Vivo
Diabetes, October 1, 2008; 57(10): 2637 - 2643.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. S. Isenberg, J. B. Maxhimer, F. Hyodo, M. L. Pendrak, L. A. Ridnour, W. G. DeGraff, M. Tsokos, D. A. Wink, and D. D. Roberts
Thrombospondin-1 and CD47 Limit Cell and Tissue Survival of Radiation Injury
Am. J. Pathol., October 1, 2008; 173(4): 1100 - 1112.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Belmadani, M. Zerfaoui, H. A. Boulares, D. I. Palen, and K. Matrougui
Microvessel vascular smooth muscle cells contribute to collagen type I deposition through ERK1/2 MAP kinase, {alpha}v{beta}3-integrin, and TGF-{beta}1 in response to ANG II and high glucose
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H69 - H76.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. Dabir, T. E. Marinic, I. Krukovets, and O. I. Stenina
Aryl Hydrocarbon Receptor Is Activated by Glucose and Regulates the Thrombospondin-1 Gene Promoter in Endothelial Cells
Circ. Res., June 20, 2008; 102(12): 1558 - 1565.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Society for Investigative Pathology.